StreetInsider.com News Articles

Form 4 MediWound Ltd. For: Aug 26 Filed by: Hess Shmuel

Fri, 28 Aug 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260828/26997775.html

Form 4 MediWound Ltd. For: Aug 26 Filed by: Hess Shmuel

Fri, 28 Aug 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260828/26997775.html

Form 144 MediWound Ltd. Filed by: Hess Shmuel

Fri, 28 Aug 2026 06:36:00 -0400

si-local-file:///var/storage/secattach/20260828/26992844.html

Form 144 MediWound Ltd. Filed by: Hess Shmuel

Fri, 28 Aug 2026 06:36:00 -0400

si-local-file:///var/storage/secattach/20260828/26992844.html

Form SCHEDULE 13G/A MediWound Ltd. Filed by: HOLD Alapkezelo Zrt.

Fri, 28 Aug 2026 06:24:00 -0400

si-local-file:///var/storage/secattach/20260828/26992724.html

Form SCHEDULE 13G/A MediWound Ltd. Filed by: HOLD Alapkezelo Zrt.

Fri, 28 Aug 2026 06:24:00 -0400

si-local-file:///var/storage/secattach/20260828/26992724.html

Form SCHEDULE 13G/A MediWound Ltd. Filed by: PRICE T ROWE ASSOCIATES INC /MD/

Fri, 14 Aug 2026 10:39:00 -0400

si-local-file:///var/storage/secattach/20260814/26926624.html

Form SCHEDULE 13G/A MediWound Ltd. Filed by: PRICE T ROWE ASSOCIATES INC /MD/

Fri, 14 Aug 2026 10:39:00 -0400

si-local-file:///var/storage/secattach/20260814/26926624.html

MediWound Ltd (MDWD) PT Lowered to $30 at Oppenheimer

Fri, 14 Aug 2026 08:33:50 -0400

Oppenheimer analyst Jay Olson lowered the price target on MediWound Ltd (NASDAQ: MDWD) to $30.00 (from $32.00) while maintaining a Outperform rating.

Form 6-K MediWound Ltd. For: Jun 30

Thu, 13 Aug 2026 07:06:00 -0400

si-local-file:///var/storage/secattach/20260813/26916304.html

Form 6-K MediWound Ltd. For: Jun 30

Thu, 13 Aug 2026 07:06:00 -0400

si-local-file:///var/storage/secattach/20260813/26916304.html

MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Thu, 13 Aug 2026 07:00:00 -0400

EscharEx^® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027

Master Services Agreement Signed with Vericel Under its BARDA Contract for NexoBrid^®

Second Quarter Revenue of $3.1 Million; Full-Year 2026 Revenue Guidance of $24–26 Million Reaffirmed

Conference Call Today at 8:30 a.m. Eastern Time

YAVNE, Israel, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the second quarter ended June 30, 2026, and provided a

MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Thu, 13 Aug 2026 07:00:00 -0400

EscharEx^® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027

Master Services Agreement Signed with Vericel Under its BARDA Contract for NexoBrid^®

Second Quarter Revenue of $3.1 Million; Full-Year 2026 Revenue Guidance of $24–26 Million Reaffirmed

Conference Call Today at 8:30 a.m. Eastern Time

MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Thu, 13 Aug 2026 07:00:00 -0400

EscharEx^® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027

Master Services Agreement Signed with Vericel Under its BARDA Contract for NexoBrid^®

Second Quarter Revenue of $3.1 Million; Full-Year 2026 Revenue Guidance of $24–26 Million Reaffirmed

Conference Call Today at 8:30 a.m. Eastern Time

MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Thu, 13 Aug 2026 07:00:00 -0400

EscharEx^® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027

Master Services Agreement Signed with Vericel Under its BARDA Contract for NexoBrid^®

Second Quarter Revenue of $3.1 Million; Full-Year 2026 Revenue Guidance of $24–26 Million Reaffirmed

Conference Call Today at 8:30 a.m. Eastern Time

MediWound to Report Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 08:00:00 -0400

MediWound to Report Second Quarter 2026 Financial Results

Conference Call and Webcast Scheduled for Thursday, August 13 at 8:30 a.m. Eastern Time

YAVNE, Israel, July 29, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will release its financial results for the second quarter ended June 30, 2026, on Thursday, August 13, 2026.

On the same day, MediWound’s management will host a conference call and live webcast at 8:30 a.m. Eastern Time to discuss the financial results and provide a corporate

MediWound to Report Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 08:00:00 -0400

MediWound to Report Second Quarter 2026 Financial Results

Conference Call and Webcast Scheduled for Thursday, August 13 at 8:30 a.m. Eastern Time

On the same day, MediWound’s management will host a conference call and live webcast at 8:30 a.m. Eastern Time to discuss the financial results and provide a corporate

MediWound to Report Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 08:00:00 -0400

MediWound to Report Second Quarter 2026 Financial Results

Conference Call and Webcast Scheduled for Thursday, August 13 at 8:30 a.m. Eastern Time

On the same day, MediWound’s management will host a conference call and live webcast at 8:30 a.m. Eastern Time to discuss the financial results and provide a corporate

MediWound to Report Second Quarter 2026 Financial Results

Wed, 29 Jul 2026 08:00:00 -0400

MediWound to Report Second Quarter 2026 Financial Results

Conference Call and Webcast Scheduled for Thursday, August 13 at 8:30 a.m. Eastern Time

On the same day, MediWound’s management will host a conference call and live webcast at 8:30 a.m. Eastern Time to discuss the financial results and provide a corporate

Form 4 MediWound Ltd. For: Jun 03 Filed by: SHAMIR NACHUM

Thu, 04 Jun 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260604/26605581.html

Form 4 MediWound Ltd. For: Jun 03 Filed by: SHAMIR NACHUM

Thu, 04 Jun 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260604/26605581.html

Form 4 MediWound Ltd. For: Jun 01 Filed by: Fox David Morton

Tue, 02 Jun 2026 07:30:00 -0400

si-local-file:///var/storage/secattach/20260602/26587484.html

Form 4 MediWound Ltd. For: Jun 01 Filed by: Fox David Morton

Tue, 02 Jun 2026 07:30:00 -0400

si-local-file:///var/storage/secattach/20260602/26587484.html

Form 4 MediWound Ltd. For: May 29 Filed by: Rubinstein Samuel

Mon, 01 Jun 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260601/26578934.html

Form 4 MediWound Ltd. For: May 29 Filed by: Rubinstein Samuel

Mon, 01 Jun 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260601/26578934.html